altimmune
present
upcoming
investor
conferences
gaithersburg
globe
newswire
altimmune
nasdaq
alt
biopharmaceutical
company
today
announced
management
present
following
upcoming
virtual
investor
conferences
october
wainwright
annual
nash
investor
conference
monday
october
pm
et
guggenheim
securities
annual
vaccines
infectious
diseases
day
monday
october
pm
et
wainwright
presentation
webcast
accessed
visiting
investor
relations
section
company
website
events
presentations
altimmune
altimmune
clinical
stage
biopharmaceutical
company
focused
developing
intranasal
vaccines
immune
modulating
therapies
treatments
liver
disease
company
diverse
pipeline
includes
proprietary
intranasal
vaccines
anthrax
influenza
intranasal
immune
modulating
therapeutic
next
generation
peptide
therapeutics
nash
chronic
hepatitis
b
heptcell
information
altimmune
please
visit
investor
contacts
